| Zum Hauptmenu. | Zum Bereichsmenu. | Zur Metanavigation. | Zur Suche. | Direkt zum Inhalt.
In Q3 2006, Wacker Chemie AG boosted year-on-year sales and earnings by 20 percent respectively, thanks particularly to continued strength of the company’s semiconductor business.
Today, the Munich-based WACKER Group officially started production in the second stage of its new monomer plant in Nünchritz (in the German state of Saxony).
At the CHi Personal Care & Homecare Ingredients Exhibition, from October 25 to 26 in Warsaw, Poland, WACKER SILICONES will be presenting a novel silicone emulsion which for the first time enables the manufacture of highly effective water-based silicone impregnants for various household care applications.
The Munich-based WACKER Group received a European Innovation Award for Cosmetics and Chemical Raw Materials on October 10 at the 53rd SEPAWA Conference in Würzburg, Germany.
An agreement signed between Wacker Biotech GmbH and Evolutec Group plc (AIM code: EVC) contracts Wacker Biotech as partner for the process development and GMP-compliant production of Evolutec’s protein drug development candidate rEV576 for clinical trials.